Show simple item record

dc.contributor.authorGore, Albert
dc.contributor.authorOwens, Steve
dc.date2021-11-25T13:36:31.000
dc.date.accessioned2021-11-26T12:29:57Z
dc.date.available2021-11-26T12:29:57Z
dc.date.issued2015-10-06T12:10:56-07:00
dc.identifierylpr/vol3/iss2/4
dc.identifier.contextkey7685499
dc.identifier.urihttp://hdl.handle.net/20.500.13051/17167
dc.description.abstractSince recombinant DNA technology was first developed in the early 1970's, society has been faced with the immense task of overseeing its use and development. Scientists have been concerned with continuing their research free from burdensome regulations, while policy-makers have worried about the potential for a biotechnological disaster if such research remains unregulated. Accordingly, attempts to control the technology's potential dangers while encouraging exploration of its benefits have caused many conflicts, both within and between the scientific and regulatory communities.
dc.titleThe Challenge of Biotechnology
dc.source.journaltitleYale Law & Policy Review
refterms.dateFOA2021-11-26T12:29:58Z
dc.identifier.legacycoverpagehttps://digitalcommons.law.yale.edu/ylpr/vol3/iss2/4
dc.identifier.legacyfulltexthttps://digitalcommons.law.yale.edu/cgi/viewcontent.cgi?article=1057&context=ylpr&unstamped=1


Files in this item

Thumbnail
Name:
24_3YaleL_PolyRev336_1984_1985_.pdf
Size:
1.257Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record